[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Farias et al., 2001 - Google Patents

Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation

Farias et al., 2001

Document ID
17625887494248936828
Author
Farias W
Nazareth R
Mourão P
Publication year
Publication venue
Thrombosis and Haemostasis

External Links

Snippet

Sulfated D-galactans occur on the red algae Botryocladia occidentalis as three fractions that differ in their sulfate content. Fractions F2 and F3 are potent anticoagulants. Like heparin, they enhance thrombin and factor Xa inhibition by antithrombin and/or heparin cofactor II …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Similar Documents

Publication Publication Date Title
Farias et al. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation
Mourão Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives
Barrowcliffe et al. Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides
Millet et al. Antithrombotic and anticoagulant activities of a low molecular weight fucoidan by the subcutaneous route
Mourão et al. Searching for alternatives to heparin: sulfated fucans from marine invertebrates
Mauray et al. Venous antithrombotic and anticoagulant activities of a fucoidan fraction
Holmer et al. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits
Pacheco et al. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm
Nader et al. Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities
Yoon et al. The medicinal plant Porana volubilis contains polysaccharides with anticoagulant activity mediated by heparin cofactor II
Pavão Glycosaminoglycans analogs from marine invertebrates: Structure, biological effects, and potential as new therapeutics
Linhardt et al. Dermatan sulfate as a potential therapeutic agent
Thomas et al. A low molecular weight heparin compared with unfractionated heparin
US5576304A (en) Antithrombotic composition
Murata et al. Inhibitory effect of chitin heparinoids on the lung metastasis of B16‐BL6 melanoma
EP0048231A1 (en) Oligosaccharides having selective anticoagulation activity
Zancan et al. Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans
Jurd et al. Anticoagulant properties of sulphated polysaccharides and a proteoglycan from Codium fragile ssp. atlanticum
AU694177B2 (en) Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
Scully et al. Anticoagulant and antiheparin activities of a pentosan polysulphate
JP2001514630A (en) Sulfated oligosaccharides with anticoagulant / antithrombotic activity
Glauser et al. Marine sulfated glycans with serpin-unrelated anticoagulant properties
Vicente et al. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding
Olson et al. Mechanism of action of heparin and heparin-like antithrombotics
Barrowcliffe et al. Heparin and bleeding: an association with lipase release